Skip to main content
SpringerLink
Log in

Sonstige Indikationen von Clonidin. Clonidin: Forschungsinstrument und Therapeutikum

  • Chapter
Zentrale Blutdruckregulation durch α 2-Rezeptorenstimulation

  • 14 Accesses

Zusammenfassung

Seit Sciner Erstanwendung am Menschen hat Clonidin aufgrund Scines spezifischen Wirkungsmechanismus, der Alpha2 -Rezeptorenstimulation, die eine Reduktion neuronaler noradrenerger Aktivität bewirkt, Physiologie und Pathophysiologie um neue Erkenntnisse bereichert. Dies führte auch dazu, daß die Substanz Clonidin, ursprünglich als Antihypertonikum in Anwendung, bei einer Reihe weiterer Erkrankungen genutzt werden kann. Das Spektrum der Erkrankungen, die durch Clonidin günstig zu beeinflussen sind, ist immer noch nicht vollständig bekannt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aghajanian GK: Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by Clonidine. Nature 276:186–187 (1978).

    Article  PubMed  CAS  Google Scholar 

  2. Ahsanuddin K: Tourette’s Syndrome — Treatment with Clonidine, a Centrally Acting Alpha-Adrenergic Agonist. Drug Intell Clin Pharmacy 14:4, 288–292 (1980).

    Google Scholar 

  3. Barr W: Problems Related to Postmenopausal Women. S A Medical Journal 49:437–439 (1975).

    CAS  Google Scholar 

  4. Beckmann H: Biochemische Grundlagen der endogenen Depression. Nervenarzt 49: 557–568 (1978).

    PubMed  CAS  Google Scholar 

  5. Björkvist SE: Clonidine in Alcohol Withdrawal. Acta psychiat scand 52:256–263 (1975).

    Article  Google Scholar 

  6. Bolli P et al: Clondine in Menopausal Flushing: A Double-Blind Trial. N Z Med J 548: 196–197 (1975).

    Google Scholar 

  7. Bottari SP et al: Hormonal Regulation of Adrenergic Receptor Subtypes in Human Myometrium. vortrag gehalten auf dem VIth F.R.E.S.E.R.H. Internat. Symp., Uterine Contractility, Brüssel 22.–24. 9. 1982.

    Google Scholar 

  8. Bravalo EL et al: Clonidine-Suppression Test. A Useful Aid in the Diagnosis of Pheochro-mocytoma. New Engl J Med 305:623–626 (1982).

    Article  Google Scholar 

  9. Briant RH et al: Interaction between Clonidine and Desipramine in Man. Brit Med J 1:522–523(1973).

    Article  PubMed  CAS  Google Scholar 

  10. Casper RF et al: Menopausal Flushes: A Neuroendocrine Link with Pulsatile Luteinizing Hormone Secretion. Science 205:823–825 (1979).

    Article  PubMed  CAS  Google Scholar 

  11. Charney DS et al: Iatrogenic Opiate Addiction: Successful Detoxification with Clonidine. Am J Psychiatry 137:989–990 (1980).

    PubMed  CAS  Google Scholar 

  12. Charney DS et al: The Clinical Use of Clonidine in Abrupt Withdrawal From Methadone. Arch Gen Psychiatry 38:1273–1277 (1981).

    Article  PubMed  CAS  Google Scholar 

  13. Charney DS et al: Adrenergic Receptor Sensitivity in Depression. Arch Gen Psychiatry 39:290–294(1982).

    Article  PubMed  CAS  Google Scholar 

  14. Checkley SA et al: Growth Hormone and other Responses to Clonidine in Patients with Endogenous Depression. Brit J Psychiat 138:51–55 (1981).

    Article  PubMed  CAS  Google Scholar 

  15. Clayden JR: Effect of Clonidine on Menopausal Flushing Lancet 2:1361 (1972).

    CAS  Google Scholar 

  16. Clayden JR et al: Menopausal Flushing: Double-Blind Trial of a Non-Hormonal Medication. Brit Med J 1:409–412 (1974).

    Article  PubMed  CAS  Google Scholar 

  17. Clayden JR: A GP’s personal experience of a clinical trial. MIMS Magazine, 33–39, March 1981.

    Google Scholar 

  18. Cohen DJ et al: Clonidine in Tourette’s Syndrome Lancet 2:551–553 (1979).

    CAS  Google Scholar 

  19. Cohen DJ et al: Clonidine Ameliorates Gilles de la Tourette Syndrome. Arch Gen Psychiatry 37:1350–1357 (1980).

    Article  PubMed  CAS  Google Scholar 

  20. Cottereau MJ et al: Essai de la Clonidine dans le sevalrage des toxicomanies aux opiacés. La Nouvelle Presse Médicale, Nr. 40, 3267 (1979).

    Google Scholar 

  21. Dorsey R: Clonidine and Gilles de la Tourette Syndrome. Arch Gen Psychiatry 38:1185 (1981).

    Article  PubMed  CAS  Google Scholar 

  22. Edington RF et al: Clonidine (Dixarit) for menopausal flushing. CMA Journal 123:23–26 (1980).

    CAS  Google Scholar 

  23. Elliott HL et al: Pharmacodynamic Studies on Mianserin and Its Interaction with Clonidine. Eur J Clin Pharmacol 21:97–102 (1981).

    Article  PubMed  CAS  Google Scholar 

  24. Evans J et al: Low-Dosage Clonidine (Dixarit) in Menopausal Flushing. Med J Aust 2:45–46(1979).

    PubMed  CAS  Google Scholar 

  25. Fielding S et al: Antinociceptive Actions of Clonidine. In: Psychopharmacology of Clonidine. Ed Lal H Fielding S; Alan R Liss Inc, New York, 1981.

    Google Scholar 

  26. Forssberg H et al: The locomotion of the acute spinal cat injected with Clonidine i.val. Brain Research 50:184–186 (1973).

    Article  PubMed  CAS  Google Scholar 

  27. Franz DN et al: Spinal Sympathetic Neurons: Possible Sites of Opiate-Withdrawal Suppression by Clonidine. Science 215:1643–1645 (1982).

    Article  PubMed  CAS  Google Scholar 

  28. Freedman R et al: Clonidine Therapy for Coexisting Psychosis and Tardive Dyskinesia. Am J Psychiatry 137:629–630 (1980).

    PubMed  CAS  Google Scholar 

  29. Freedman R et al: Clonidine treatment of schizophrenia: Double-Blind Comparison to Placebo and Neuroleptic Drugs. Acta psychiat scand 65:35–45 (1982).

    Article  PubMed  CAS  Google Scholar 

  30. Fozard JR: Comparative Effects of Four Migraine Prophylactic Drugs on an Isolated Extracranial Artery. Eur J Pharmacol 36:127–139 (1976).

    Article  PubMed  CAS  Google Scholar 

  31. Gáspár L et al: Clonidine Suppression Test in Pheochromocytoma. New Engl J Med 307:189–190 (1982).

    PubMed  Google Scholar 

  32. Garcia-Sevilla JA et al: Platelet Alpha2-Adrenergic Receptors in Major Depressive Disorder. Arch Gen Psychiatry 38:1327–1333 (1981).

    Article  PubMed  CAS  Google Scholar 

  33. Gil-Ad I et al: Oral Clonidine as a Growth Hormone Stimulation Test. Lancet 2:278–282 (1979).

    Article  PubMed  CAS  Google Scholar 

  34. Gold MS et al: Clonidine in Opiate Withdrawal. Lancet 1:929–930 (1978/1).

    Article  PubMed  CAS  Google Scholar 

  35. Gold MS et al: Clonidine Blocks Acute Opiate-Withdrawal Symptoms. Lancet 2:599–602 (1978/11).

    Article  PubMed  CAS  Google Scholar 

  36. Gold MS et al: Clonidine Decreases Opiate Withdrawal-Related Anxiety: Possible Opiate Noradrenergic Interaction in Anxiety and Panic. Substance and Alcohol Actions/MISUSE 1:239–246(1980/I).

    PubMed  CAS  Google Scholar 

  37. Gold MS et al: Opiate Withdrawal Using Clonidine: A Safe, Effective, and Rapid Nonopiate Treatment. JAMA 243:343–346 (1980/II).

    Article  PubMed  CAS  Google Scholar 

  38. Gold MS et al: Efficacy of Clonidine in Opiate Withdrawal: A Study of Thirty Patients. Drug and Alcohol Dependence 6:201–208 (1980/III).

    Article  PubMed  CAS  Google Scholar 

  39. Gold MS et al: Clinical Utility of Clonidine in Opiate Withdrawal: A Study of 100 Patients. In: Psychopharmacology of Clonidine, Ed: Lal H, Fielding S; Alan R Liss Inc, New York, 1981.

    Google Scholar 

  40. Haggerty JJ et al: Clonidine Therapy and Meperidine Withdrawal Am J Psychiatry 138:698(1981).

    Google Scholar 

  41. Hakkarainen H et al: The Role of Clonidine in the Treatment of Migraine: A Review of the Literature and Personal Experience. Upsala, J Med Sci 31:16–19 (1980).

    CAS  Google Scholar 

  42. Halter JB et al: Clonidine-Suppression Test for Diagnosis of Pheochromozytoma. New Engl J Med 1:49–50(1982).

    Google Scholar 

  43. Hamburg M et al: Chronic morphine administration increases the apparent number of Alpha2-adrenergic receptors in rat brain. Nature 291:493–495 (1981).

    Article  PubMed  CAS  Google Scholar 

  44. Herrmann P et al: Erfahrungen beim Opiatentzug mit Clonidin. Mitteilungen der Österr. Sanitätsverwaltung II, 189–192, 1982.

    Google Scholar 

  45. Hoder EL et al: Clonidine in Neonatal Narcotic-Abstinence Syndrome. New Engl J Med 305:1284(1981).

    Article  Google Scholar 

  46. Hoehn-Saric R et al: Effects of Clonidine on Anxiety Disorders. Arch Gen Psychiatry 38:1278–1282(1981).

    Article  PubMed  CAS  Google Scholar 

  47. Hornykiewicz O: Brain catecholamines in schizophrenia — a good case for noradrenaline. Nature 299:484–486 (1982).

    Article  PubMed  CAS  Google Scholar 

  48. Hunt GE et al: The Tetracyclic Antidepressant Mianserin: Evaluation of its Blockade of Presynaptic Alpha-Adrenoceptors in a Self-Stimulation Model Using Clonidine. Eur J Pharmacol 70:59–63 (1981).

    Article  PubMed  CAS  Google Scholar 

  49. Jimerson DC et al: Preliminary Trial of the Noradrenergic Agonist Clonidine in Psychiatric Patients. Biol Psychiatry 15:45–57 (1980).

    PubMed  CAS  Google Scholar 

  50. Jouvent R et al: Antimanic Effect of Clonidine. Am J Psychiatry 137:1275–1276 (1980).

    PubMed  CAS  Google Scholar 

  51. Kass B et al: Propranolol (Inderal) and Clonidine (Catapressan) in the prophylactic treatment of migraine. Acta neurol scandinaval 61:351–356 (1980).

    Article  CAS  Google Scholar 

  52. Keup W: Clonidin im Opiat-Entzug: Grundlagen der Anwendung. Münch med Wschr 124:148–152 (1982).

    CAS  Google Scholar 

  53. Knesevich JW: Successful Treatment of Obsessive-Compulsive Disorder with Clonidine Hydrochloride. Am J Psychiatry 139:364–365 (1982).

    PubMed  CAS  Google Scholar 

  54. Kobinger W: Clonidine, a drug with many faces? Trends Pharmacol Sci 2:194–196 (1981).

    Article  CAS  Google Scholar 

  55. Krulich L et al: Differential Effects of Pharmacological Manipulations of Central Alpha1- and Alpha2-Adrenergic Receptors on the Secretion of Thyrotropin (TSH) and Growth Hormone (GH) in Male Rats. Departments of Physiology and Pharmacology, Univ. of Texas Health Science Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75235, zur Publ. eingereicht.

    Google Scholar 

  56. Lal S et al: Effect of Clonidine on Growth Hormone, Protaction, Luteining Hormone, Follicle Stimulating Hormone and Tyroid Stimulating Hormone in the Serum of Normal Man. J Clin Endocrinol Metab 41:827–832 (1975).

    Article  PubMed  CAS  Google Scholar 

  57. Lauritzen C: Behandlung klimakterischer Beschwerden mit niedrig dosiertem Clonidin. Dtsch med Wschr 197:335–338 (1982).

    Article  Google Scholar 

  58. Lechin F et al: Physiological, Clinical and Therapeutical Basis of a New Hypothesis of Headache. Headache 20:77–89 (1980).

    Article  PubMed  CAS  Google Scholar 

  59. Lechin F et al: On the Use of Clonidine and Thioproperazine in a Woman with Gilles de la Tourette’s Disease. Biological Psychiatry 17:1, 103–108 (1982).

    PubMed  CAS  Google Scholar 

  60. Levens LK: Clonidine in Treatment of Dysmenorrhoea. Brit Med J 1:577 (1974).

    Article  PubMed  CAS  Google Scholar 

  61. Liebowitz MR et al: Clonidine Treatment of Panic Disorder was evaluated. Psychopharmacol Bull 17:3, 122–123(1981).

    Google Scholar 

  62. Lindsay R et al: Failure of response of menopausal vasomotor symptoms to Clonidine. Maturitas 1:21–25 (1978).

    Article  PubMed  CAS  Google Scholar 

  63. Matussek N: Effect of Amphetamine and Clonidine on Human Growth Hormone Release in Psychiatric Patients and Controls. Symposium Rome, May 9–11, 1977 publ. in: Symposia Medica Hoechst 13:431–446 (1978) Stuttgart, New York: Schattauer, 1978.

    Google Scholar 

  64. Matussek N et al: Effect of Clonidine on Growth Hormone Release in Psychiatric Patients and Controls. Psychiatry Research 2:25–36 (1980).

    Article  PubMed  CAS  Google Scholar 

  65. McEntee WJ et al: Memory Impairment in Korsakoff’s Psychosis: A Correlation with Brain Noradrenergic Activity. Science 202:905–907 (1978).

    Article  PubMed  CAS  Google Scholar 

  66. McEntee WJ et al: Memory Enhancement in Korsakoff s Psychosis by Clonidine: Further Evidence for a Noradrenergic Deficit. Ann Neurol 7:446–470 (1980).

    Article  Google Scholar 

  67. McEntee WJ et al: Clonidine in Korsakoff Disease: Pathophysiology and Therapeutic Implications. In: Psychopharmacology of Clonidine, Ed: Lal H; Fielding S; Alan R Liss Inc, New York, 1981.

    Google Scholar 

  68. Metz G: (Publikation in vorbereitung).

    Google Scholar 

  69. Metz SA et al: Autonomic epilepsy: Clonidine blockade of paroxysmal catecholamine release and flushing. Ann intern Med 88:189–193 (1978).

    PubMed  CAS  Google Scholar 

  70. Naftchi NE: Functional Restoration of the Traumatically Injured Spinal Cord in Cats by Clonidine. Science 217:1042–1044 (1982).

    Article  PubMed  CAS  Google Scholar 

  71. Nardoni A et al: Clonidine in the Treatment of the Alcoholic Abstinence Syndrome (Preliminary Report) (unveröffentlichter Bericht).

    Google Scholar 

  72. Nishikawa T et al: Tardive Dyskinesia Treated with Clonidine. Kurume Med J 27:209–210 (1980).

    Article  PubMed  CAS  Google Scholar 

  73. Nutt JG et al: Effects of Baclofen, GABA Mimetics and Adrenergic Agents on the Flexor Reflex of the Chronic Spinal Rat. NIH Guide for Grants and Contracts, App. 1, 7:17 (1978).

    Google Scholar 

  74. Papanicolaou J et al: Anticonvalulsant Effects of Clonidine Mediated Through Central Alpha2-Adrenoceptors. Eur J Pharmacol 77:163–166 (1982).

    Article  PubMed  CAS  Google Scholar 

  75. Plant TM et al: The Sites of Action of Estradiol and Phentolamine in the Inhibition of the Pulsatile, Circhoral Discharges of LH the Rhesus Monkey (Macaca mulatta). Endocrinology 102:1015–1018(1978).

    Article  PubMed  CAS  Google Scholar 

  76. Putkonen PTS et al: Clonidine alleviates cataplectic symptoms in narcolepsy. Depts. of Neurology and Physiology, Univ. of Helsinki (unveröffentlichter Bericht).

    Google Scholar 

  77. Rao MS et al: Use of Clonidine in the Management of Patients with Neurogenic Bladder Dysfunction. Eur Urol 6:261–264 (1980).

    PubMed  CAS  Google Scholar 

  78. Redmond DE et al: II. New Evidence for a Locus Coeruleus-Norepinephrine Connection with Anxiety. Life Sciences 25:2149–2162 (1979).

    Article  PubMed  CAS  Google Scholar 

  79. Reichl R et al: Inhibition of Neurosympathetic Cerebroarterial Constriction by Clonidine in Cats. Eur J Pharmacol 68:349–357 (1980).

    Article  PubMed  CAS  Google Scholar 

  80. Roth RH et al: Clonidine Suppression of Noradrenergic Hyperactivity During Morphine Withdrawal By Clonidine: Biochemical Studies in Rodents and Primates. J Clin Psychiatry 43:42–46(1982).

    PubMed  CAS  Google Scholar 

  81. Rudolph CD et al: Sites at which Clonidine Acts to Affect Blood Pressure and the Secretion of Renin, Growth Hormone and ACTH. Neuroendocrinology 31:121–128 (1980).

    Article  PubMed  CAS  Google Scholar 

  82. Salmi T et al: Clonidine in the treatment of menopausal symptoms. Int J Gynaecol Obstet 16:422–426(1979).

    PubMed  CAS  Google Scholar 

  83. Salti R et al: Oral Clonidine: an effective provalocative test of growth hormone release. Helval paediat Acta 36:527–531 (1981).

    CAS  Google Scholar 

  84. Sar M et al: Central noradrenergic neurones concentrate 3H-oestradiol. Nature 289:500–502 (1981).

    Article  PubMed  CAS  Google Scholar 

  85. Schindler AE et al: Studies with Clonidine (Dixarit) in Menopausal Women. Arch Gynecol 227:341–347(1979).

    Article  PubMed  CAS  Google Scholar 

  86. Shapiro AK et al: Clonidine and Haloperidol in Gilles de la Tourette Syndrome. Arch Gen Psychiatry 38:1183–1184 (1981).

    Article  PubMed  CAS  Google Scholar 

  87. Siever LJ et al: Growth Hormone Response to Clonidine as a Probe of Noradrenergic Receptor Responsiveness in Affective Disorder Patients and Controls. Psychiatry Res 6:171–183(1982).

    Article  PubMed  CAS  Google Scholar 

  88. Simpson GM et al: A Preliminary Evaluation of the Sedative Effects of Catapres, a New Antihypertensive Agent, in Chronic Schizophrenic Patients. J Clin Pharmacol 7:221–225 (1967).

    CAS  Google Scholar 

  89. Sjöberg N-O: Dysmenorrhea and Uterine Neurotransmitters. Acta Obstet Gynecol Scand 87:57–59(1979).

    Article  Google Scholar 

  90. Smith CB et al: Platelet Alpha2-Adrenoreceptors in Melancholia. J Pharmacol Exp Ther 215:413(1980).

    Google Scholar 

  91. Sonnendecker EWW et al: A comparison of Oestrogen-Progestogen with Clonidine in the Climacteric Syndrome. S Afr Med J 58:753–756 (1980).

    PubMed  CAS  Google Scholar 

  92. Sternberg DE et al: Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia: Effects of Clonidine in Schizophrenic Patients and Normal Controls. Arch Gen Psychiatry 39:285–289(1982).

    Article  PubMed  CAS  Google Scholar 

  93. Sugerman AA: A Pilot Study of ST-155 (Catapres) in Chronic Schizophrenics. J clin pharmac 7:226–228 (1967).

    CAS  Google Scholar 

  94. Svensson T et al: Anxiolytic Action of Clonidine. Nordisk Psykiatrisk Tidskrift 32:439–441 (1978).

    Article  Google Scholar 

  95. Sweeney DR et al: Plasma Free and Conjugated MHPG in Psychiatric Patients: A Pilot Study. Arch Gen Psychiatry 37:1100–1103 (1980).

    Article  PubMed  CAS  Google Scholar 

  96. The Health Services Human Growth Hormone Committee Comparison of the Intravenous Insulin and Oral Clonidine Tolerance Tests for Growth Hormone Secretion. Arch Dis Childhood 56:852–854 (1981).

    Google Scholar 

  97. Tseng L-F et al: Effects of Clonidine on Morphine Withdrawal Signs in the Rat. Eur J Pharmacol 30:93–99 (1975).

    Article  PubMed  CAS  Google Scholar 

  98. Tuckman J et al: Clinical Trial of an Alpha-Adrenergic Receptor Stimulating Drug (Clonidine) For Treatment of Spasticity in Spinal Cord Injured Patients. Lab. of Biochem. Pharmacol., Inst. of Rehabil. Med., New York, Univ. Medical Center, 400 East 34 Street, New York, NY 10016 (unveröffentlichter Bericht).

    Google Scholar 

  99. Uhde TW et al: Clonidine and Psychophysical Pain. Lancet 2:1375 (1980).

    Article  PubMed  CAS  Google Scholar 

  100. vetulani J et al: Depression by Clonidine of shaking behaviour elicited by nalorphine in morphine-dependent rats. J Pharm Pharmac 29:567–569 (1977).

    Article  CAS  Google Scholar 

  101. Walinder J et al: Clonidine Suppression of the Alcohol Withdrawal Syndrome. Drug and Alcohol Dependence 8:345–348 (1981).

    Article  PubMed  CAS  Google Scholar 

  102. Walland A: Inhibition of sudomotor transmission in the cat’s stellate ganglion by activation of somadendritic Alpha2-adrenoceptors (zur Publ. eingereicht).

    Google Scholar 

  103. Washton AM et al: Clonidine Hydrochloride: A Non-Opiate Treatment for Opiate Withdrawal. Psychopharmac Bull 16:50–52 (1980).

    Google Scholar 

  104. Washton AM et al: Clonidine in Opiate Withdrawal: Review and Appraisal of Clinical Findings. Pharmacotherapy 1:140–146 (1981).

    PubMed  CAS  Google Scholar 

  105. Weick RF: Acute Effects of Adrenergic Receptor Blocking Drugs and Neuroleptic Agents on Pulsatile Discharges of Luteinizing Hormone in the Ovariectomized Rat. Neuroendocrinology 26:108–117 (1978).

    Article  PubMed  CAS  Google Scholar 

  106. Wilkinson M: Clonidine for Migraine. Lancet 2:43 (1969).

    Google Scholar 

  107. Yaksh TL: Activation of Modulatory Receptor Systems in Primate Spinal Cord: The Analgesic Effects of Intrathecal Opiates, Alpha-Adrenergic Agonists and Baclofen in the Monkey. Dept. of Neurol. Surgery and Pharmacology, Mayo Foundation, Rochester, Minnesota 55901, USA (Abstract).

    Google Scholar 

  108. Ylikorkala O: Clonidine in the treatment of menopausal symptoms. Ann Chir Gynaec Fenn 64:242–245(1975).

    PubMed  CAS  Google Scholar 

  109. Young S et al: Noradrenergic Alpha1- and Alpha2-Receptors: Light Microscopic Autoradiographic Localization. Proc Natl Acad Sci USA 77:1696–1700 (1980).

    Article  PubMed  CAS  Google Scholar 

  110. Young WS III et al: Anatomical Mapping of Clonidine (Alpha2-Noradrenergic) Receptors in Rat Brain: Relationship to Function. In: Psychopharmacology of Clonidine, Ed: Lal H, Fielding S; Alan R Liss Inc, New York, 1981.

    Google Scholar 

  111. Zaimis E et al: A Possible Pharmacological Approach to Migraine. Lancet 2:298–300 (1969).

    Article  PubMed  CAS  Google Scholar 

  112. Zaimis E: Hypotensive Drugs: Peripheral versus Central Effects. J Med Sci Scand 31:52–54 (1980).

    CAS  Google Scholar 

  113. Zelnik TC et al: Clinical Response to Clonidine and Imipramine, and Platelet Alpha2-Adrenoreceptors in a Case of Agoraphobia with Panic Attacks. Biological Psychiatry 17:761–766(1982).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Boehringer Ingelheim, Postfach 200, 6507, Ingelheim/Rhein, Deutschland

    Dr. H. D. Görlich

Authors
  1. Dr. H. D. Görlich
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Abteilung, Marien-Hospital, Rochusstraße 2, 4000, Düsseldorf, Deutschland

    K. Hayduk

  2. Medizinische Klinik und Poliklinik, Universitätsklinikum Essen, Hufelandstraße 55, 4300, Essen 1, Deutschland

    K. D. Bock

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this chapter

Cite this chapter

Görlich, H.D. (1983). Sonstige Indikationen von Clonidin. Clonidin: Forschungsinstrument und Therapeutikum. In: Hayduk, K., Bock, K.D. (eds) Zentrale Blutdruckregulation durch α 2-Rezeptorenstimulation. Steinkopff. https://doi.org/10.1007/978-3-642-48440-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-48440-7_21

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0624-4

  • Online ISBN: 978-3-642-48440-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation